✦ LIBER ✦

Adjuvant bicalutamide ineffective for low-risk prostate cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide-activated oncolytic adenovi

✍ Johnson, T J; Höti, N; Liu, C; Chowdhury, W H; Li, Y; Zhang, Y; Lupold, S E; DeW 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 733 KB

Bicalutamide as adjuvant therapy warrant

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 143 KB

Cost-Effectiveness Analysis of Bicalutam

✍ Karen Moeremans; Karin Caekelbergh; Lieven Annemans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Prostate-Specific Antigen Control with L

✍ O. Kenneth Macdonald; R. Jeffrey Lee; Greg Snow; Christopher M. Lee; Jonathan D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Low dose postoperative adjuvant radiatio

✍ Cummings, B.; Hawkins, N.; Keane, T.; O'Sullivan, B.; Wong, S.; Feigen, M. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 622 KB

INTERSTITIAL PNEUMONITIS FOLLOWING BICAL

✍ McCAFFREY, JOHN A.; SCHER, HOWARD I. 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 140 KB